Cosmo Pharmaceuticals Full Year 2024 Earnings: In Line With Expectations

Cosmo Pharmaceuticals Full Year 2024 Earnings: In Line With Expectations
Profit margin increased to 50% from a net loss in FY 2023 due to higher revenue. Revenue met analyst estimates, and EPS was in line with expectations. Future revenue is forecasted to grow at 22% p.a. over the next 3 years.